Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nitric Oxide ; 76: 152-163, 2018 06 01.
Article in English | MEDLINE | ID: mdl-28943473

ABSTRACT

Hydrogen sulphide (H2S) is a gasotransmitter that participates in various physiological and pathophysiological processes within the gastrointestinal tract. We studied the effects and possible mechanism of action of H2S in secretory diarrhoea caused by cholera toxin (CT). The possible mechanisms of action of H2S were investigated using an intestinal fluid secretion model in isolated intestinal loops on anaesthetized mice treated with CT. NaHS and Lawesson's reagent and l-cysteine showed antisecretory activity through reduction of intestinal fluid secretion and loss of Cl- induced by CT. Pretreatment with an inhibitor of cystathionine-γ-lyase (CSE), dl-propargylglycine (PAG), reversed the effect of l-cysteine and caused severe intestinal secretion. Co-treatment with PAG and a submaximal dose of CT increased intestinal fluid secretion, thus supporting the role of H2S in the pathophysiology of cholera. CT increased the expression of CSE and the production of H2S. Pretreatment with PAG did not reverse the effect of SQ 22536 (an AC inhibitor), bupivacaine (inhibitor of cAMP production), KT-5720 (a PKA inhibitor), and AICAR (an AMPK activator). The treatment with Forskolin does not reverse the effects of the H2S donors. Co-treatment with either NaHS or Lawesson's reagent and dorsomorphin (an AMPK inhibitor) did not reverse the effect of the H2S donors. H2S has antisecretory activity and is an essential molecule for protection against the intestinal secretion induced by CT. Thus, H2S donor drugs are promising candidates for cholera therapy. However, more studies are needed to elucidate the possible mechanism of action.


Subject(s)
Cholera Toxin/antagonists & inhibitors , Diarrhea/chemically induced , Diarrhea/drug therapy , Hydrogen Sulfide/pharmacology , Signal Transduction , AMP-Activated Protein Kinases/metabolism , Adenylyl Cyclases/metabolism , Animals , Cholera Toxin/pharmacology , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Female , Male , Mice
2.
Int J Biol Macromol ; 105(Pt 1): 1105-1116, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28751047

ABSTRACT

Inflammation is a protective reaction of the microcirculation. However, sustained inflammation can lead to undesired effects. Thuja occidentalis Linn has many pharmacological properties but has no anti-inflammatory activity described. Thus, this study aims evaluating the anti-inflammatory activity of the aqueous extract (AE) and the polysaccharide fraction (PLS) of T. occidentalis L. in mice. The results of our evaluations in various experimental models indicated that AE and PLS (3, 10, and 30mg/kg, i.p.) reduced (p˂0.05) paw edema induced by carrageenan, dextran sulfate (DEX), compound 48/80, serotonin (5-HT), bradykinin (BK), histamine (HIST), and prostaglandin E2 (PGE2). Furthermore, it inhibited neutrophils recruitment; decreased MPO activity, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels, vascular permeability, nitrite concentration, and MDA concentration; and maintained the GSH levels in the peritoneal exudate. The AE and PLS reduced neutrophil infiltration and cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) immunostaining in paw tissue. Treatment with the AE and PLS (300mg/kg) did not induce gastric toxicity. In conclusion, these results show that the AE and PLS reduced the inflammatory response by inhibiting vascular and cellular events, inhibiting pro-inflammatory cytokine production, and reducing oxidative stress. Furthermore, they did not induce gastric toxicity at high doses.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Polysaccharides/pharmacology , Thuja/chemistry , Water/chemistry , Animals , Anti-Inflammatory Agents/therapeutic use , Capillary Permeability/drug effects , Edema/drug therapy , Edema/metabolism , Glutathione/metabolism , Interleukin-6/metabolism , Male , Malondialdehyde/metabolism , Mice , Nitric Oxide/biosynthesis , Peritoneal Cavity , Peritonitis/drug therapy , Peroxidase/metabolism , Polysaccharides/therapeutic use , Tumor Necrosis Factor-alpha/metabolism
3.
Chem Biol Interact ; 229: 55-63, 2015 Mar 05.
Article in English | MEDLINE | ID: mdl-25656915

ABSTRACT

Inflammation is a local tissue response to attacks characterized by vascular and cellular events, including intense oxidative stress. Riparin A, a compound obtained from Aniba riparia, has been shown to have antioxidant activity and cytotoxicity in vitro. This study was aimed at evaluating the anti-inflammatory effect of riparin A against acute inflammation. The results of our evaluations in various experimental models indicated that riparin A reduced paw edema induced by carrageenan, compound 48/80, histamine, and serotonin. Furthermore, it decreased leukocyte and neutrophil counts, myeloperoxidase activity, thiobarbituric acid reactive substance (TBARS) levels, and cytokine (tumor necrosis factor-α and interleukin-1ß) levels increased by carrageenan-induced peritonitis, and reversed glutathione levels. Riparin A also reduced carrageenan-induced adhesion and rolling of leukocytes on epithelial cells and did not produce gastric-damage as compared with indomethacin. In conclusion, the data show that riparin A reduces inflammatory response by inhibiting vascular and cellular events, modulating neutrophil migration, inhibiting proinflammatory cytokine production, and reducing oxidative stress.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Benzamides/therapeutic use , Carrageenan/adverse effects , Edema/drug therapy , Immune System Diseases/drug therapy , Leukocyte Disorders/drug therapy , Neutrophils/drug effects , Peritonitis/drug therapy , Phenethylamines/therapeutic use , Animals , Anti-Inflammatory Agents/isolation & purification , Antioxidants/isolation & purification , Antioxidants/therapeutic use , Benzamides/isolation & purification , Carrageenan/immunology , Cell Adhesion/drug effects , Cytokines/immunology , Edema/chemically induced , Edema/immunology , Edema/pathology , Extremities/pathology , Immune System Diseases/chemically induced , Immune System Diseases/immunology , Immune System Diseases/pathology , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/immunology , Inflammation/pathology , Lauraceae/chemistry , Leukocyte Disorders/chemically induced , Leukocyte Disorders/immunology , Leukocyte Disorders/pathology , Leukocyte Rolling/drug effects , Male , Mice , Neutrophils/immunology , Neutrophils/pathology , Oxidative Stress/drug effects , Peritonitis/chemically induced , Peritonitis/immunology , Peritonitis/pathology , Peroxidase/immunology , Phenethylamines/isolation & purification
4.
Life Sci ; 94(1): 58-66, 2014 Jan 14.
Article in English | MEDLINE | ID: mdl-24239641

ABSTRACT

AIMS: The present study aimed to investigate the potential anti-inflammatory and anti-nociceptive effects of carvacryl acetate, a derivative of carvacrol, in mice. MAIN METHODS: The anti-inflammatory activity was evaluated using various phlogistic agents that induce paw edema, peritonitis model, myeloperoxidase (MPO) activity, pro and anti-inflammatory cytokine levels. Evaluation of antinociceptive activity was conducted through acetic acid-induced writhing, hot plate test, formalin test, capsaicin and glutamate tests, as well as evaluation of motor performance on rotarod test. KEY FINDINGS: Pretreatment of mice with carvacryl acetate (75 mg/kg) significantly reduced carrageenan-induced paw edema (P<0.05) when compared to vehicle-treated group. Likewise, carvacryl acetate (75 mg/kg) strongly inhibited edema induced by histamine, serotonin, prostaglandin E2 and compound 48/80. In the peritonitis model, carvacryl acetate significantly decreased total and differential leukocyte counts, and reduced levels of myeloperoxidase and interleukin-1 beta (IL-1ß) in the peritoneal exudate. The levels of IL-10, an anti-inflammatory cytokine, were enhanced by carvacryl acetate. Pretreatment with carvacryl acetate also decreased the number of acetic acid-induced writhing, increased the latency time of the animals on the hot plate and decreased paw licking time in the formalin, capsaicin and glutamate tests. The pretreatment with naloxone did not reverse the carvacryl acetate-mediated nociceptive effect. SIGNIFICANCE: In conclusion, the current study demonstrated that carvacryl acetate exhibited anti-inflammatory activity in mice by reducing inflammatory mediators, neutrophil migration and cytokine concentration, and anti-nociceptive activity due to the involvement of capsaicin and glutamate pathways.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Monoterpenes/pharmacology , Pain/drug therapy , Animals , Cytokines/metabolism , Disease Models, Animal , Edema/drug therapy , Edema/physiopathology , Immune System Diseases/drug therapy , Inflammation/physiopathology , Inflammation Mediators/metabolism , Leukocyte Disorders/drug therapy , Male , Mice , Pain/physiopathology , Peritonitis/drug therapy , Peritonitis/physiopathology , Peroxidase/drug effects , Peroxidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...